Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.

Horiguchi, Y; Itoh, M; Takagawa, H; Imai, H; Kamei, A; Sekoguchi, B; Nagamura, Y

Horiguchi, Y; Itoh, M; Takagawa, H; Imai, H; Kamei, A; Sekoguchi, B; Nagamura, Y.

Affiliation

Horiguchi Y; Department of Internal Medicine, Fujita Health University School of Medicine, Aichi, Japan.

Cancer Chemother Pharmacol ; 31 Suppl: S60-4, 1992.

Article in En | MEDLINE | ID: mdl-1333909

Subject(s)

Carcinoma, Hepatocellular/therapy; Chemoembolization, Therapeutic; Doxorubicin/administration & dosage; Iodized Oil/administration & dosage; Liver Neoplasms/therapy; Aged; Carcinoma, Hepatocellular/mortality; Drug Stability; Humans; Liver Neoplasms/mortality; Middle Aged; Survival Rate; Suspensions

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Doxorubicin / Chemoembolization, Therapeutic / Iodized Oil / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Clinical_trials Limits: Aged / Humans / Middle aged Language: En Year: 1992 Type: Article

Search on Google

XML

PubMed Links